Rimegepant is Effective for the Acute Treatment of Migraine in Patients Who Have Discontinued or Currently Use Triptans: Results from 3 Phase 3 Clinical Trials

被引：0
|
作者：
Croop, Robert [1 ]
Jensen, Christopher [1 ]
Thiry, Alexandra [1 ]
Stock, Elyse [1 ]
Conway, Charles [1 ]
Morris, Beth [1 ]
Coric, Vladimir [1 ]
Lipton, Richard [2 ]
机构：
[1] Biohaven Pharmaceut Inc, New Haven, CT USA
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2114
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials
    Stauffer, Virginia L.
    Turner, Ira
    Kemmer, Phebe
    Kielbasa, William
    Day, Kathleen
    Port, Martha
    Quinlan, Tonya
    Camporeale, Angelo
    [J]. JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
  • [42] Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials
    Virginia L. Stauffer
    Ira Turner
    Phebe Kemmer
    William Kielbasa
    Kathleen Day
    Martha Port
    Tonya Quinlan
    Angelo Camporeale
    [J]. The Journal of Headache and Pain, 2020, 21
  • [43] Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE
    Dooley, M. A.
    Houssiau, F.
    Aranow, C.
    D'Cruz, D. P.
    Askanase, A.
    Roth, D. A.
    Zhong, Z. J.
    Cooper, S.
    Freimuth, W. W.
    Ginzler, E. M.
    [J]. LUPUS, 2013, 22 (01) : 63 - 72
  • [44] Lasmiditan is Effective in the Acute Treatment of Migraine in Patients with Insufficient Response to Triptans: Findings from the Modified-parallel, Placebo-controlled, Double-blind, Phase 3 Consistency CENTURION Study
    Reuter, U.
    Lombard, L.
    Krege, J.
    Valderas, E. Gomez
    Krikke-Workel, J.
    Agnello, G. Dell
    Dowsett, S.
    Buse, D. C.
    [J]. CEPHALALGIA, 2021, 41 (1_SUPPL) : 203 - 203
  • [45] Lasmiditan is Effective in the Acute Treatment of Migraine in Patients with Insufficient Response to Triptans: Findings from the Modified-parallel, Placebo-controlled, Double-blind, Phase 3 Consistency CENTURION Study
    Reuter, U.
    Lombard, L.
    Krege, J.
    Valderas, E. Gomez
    Krikke-Workel, J.
    Agnello, G. Dell
    Dowsett, S.
    Buse, D. C.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 136 - 136
  • [46] Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN
    Krege, John H.
    Rizzoli, Paul B.
    Liffick, Emily
    Doty, Erin G.
    Dowsett, Sherie A.
    Wang, Jianing
    Buchanan, Andrew S.
    [J]. CEPHALALGIA, 2019, 39 (08) : 957 - 966
  • [47] Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy From ACHIEVE I and ACHIEVE II Phase 3 Trials
    Hutchinson, S.
    Dodick, D. W.
    Treppendahl, C.
    Bennett, N. L.
    Yu, S.
    Trugman, J. M.
    [J]. HEADACHE, 2020, 60 : 93 - 93
  • [48] Rimegepant 75 mg Is More Effective for Migraine Than Nonsteroidal Anti-inflammatory Drugs: Post Hoc Analysis of Data From 2 Phase 3 Trials
    Blumenfeld, Andrew
    Buse, Dawn
    Turner, Ira
    Stock, David A.
    Morris, Beth A.
    Coric, Vladimir
    Croop, Robert
    [J]. CEPHALALGIA, 2019, 39 : 202 - 202
  • [49] Rimegepant 75 mg Is More Effective for Migraine Than Nonsteroidal Anti-nflammatory Drugs: Post Hoc Analysis of Data From 2 Phase 3 Trials
    Turner, Ira
    Buse, Dawn
    Blumenfeld, Andrew
    Stock, Elyse
    Stock, David
    Conway, Charles
    Jensen, Christopher
    Morris, Beth
    Coric, Vladimir
    Croop, Robert
    [J]. NEUROLOGY, 2020, 94 (15)
  • [50] Results from two phase 3 clinical trials of Linaclotide in patients with chronic constipation (CC)
    Lembo, A. J.
    Schneier, H.
    Lavins, B. J.
    Shiff, S. J.
    Macdougall, J. E.
    Kurtz, C. B.
    Currie, M. G.
    Johnston, J. M.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2010, 22 : 77 - 77
12345